###begin article-title 0
###xml 8 14 8 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 16 20 16 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 22 26 22 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTC</italic>
###xml 102 108 102 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 129 137 <span type="species:ncbi:9606">patients</span>
Role of CYP1B1, MYOC, OPTN and OPTC genes in adult-onset primary open-angle glaucoma: predominance of CYP1B1 mutations in Indian patients
###end article-title 0
###begin title 1
Purpose
###end title 1
###begin p 2
###xml 17 23 17 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 41 46 41 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
###xml 145 149 145 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTC</italic>
###xml 255 261 255 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 263 267 263 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 269 273 269 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 279 283 279 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTC</italic>
###xml 376 384 <span type="species:ncbi:9606">patients</span>
Mutations in the CYP1B1, MYOC, OPTN, and WDR36 genes result in glaucoma. Given its expression in the optic nerve, it is likely a mutation in the OPTC gene is also involved in initiating glaucoma. This study was designed to evaluate the involvement of the CYP1B1, MYOC, OPTN, and OPTC genes in the etiology of adult-onset primary open-angle glaucoma (POAG) found in 251 Indian patients.
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
###xml 281 287 281 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 326 332 326 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 425 431 425 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
Blood samples were obtained from individuals for DNA isolation. A combination of polymerase chain reaction-single strand conformation polymorphism, allele-specific PCR, and DNA sequencing techniques were used to detect mutations in four genes. Four microsatellite markers from the CYP1B1 candidate region and three intragenic CYP1B1 single nucleotide polymorphisms (SNPs) were used to determine the origin of the most common CYP1B1 mutations.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 124 130 124 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 550 556 550 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 699 703 699 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 751 755 751 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 824 828 824 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 898 902 898 902 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 1010 1014 1010 1014 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTC</italic>
###xml 1088 1094 1088 1094 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 1096 1100 1096 1100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 1106 1110 1106 1110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 207 215 <span type="species:ncbi:9606">patients</span>
###xml 565 573 <span type="species:ncbi:9606">patients</span>
###xml 661 669 <span type="species:ncbi:9606">patients</span>
###xml 793 801 <span type="species:ncbi:9606">patients</span>
###xml 884 892 <span type="species:ncbi:9606">patients</span>
###xml 959 967 <span type="species:ncbi:9606">patients</span>
###xml 1058 1066 <span type="species:ncbi:9606">patients</span>
Three previously known mutations (Pro193Leu, Glu229Lys, and Arg368His) and one novel (Met292Lys) mutation were found in the CYP1B1 gene. Frequencies of the most common mutations, Glu229Lys and Arg368His, in patients were 5.12% and 3.98%, respectively. The Glu229Lys and Arg368His mutations were also found in normal controls at frequencies of 5% and 2%, respectively, suggesting that these mutations might be polymorphic variants in our population. The absence of allele sharing for D2S177, D2S1346, D2S2974, and D2S2331 markers and three intragenic CYP1B1 SNPs in patients suggested multiple origins for the Glu229Lys and Arg368His variants. Two of 251 (0.8%) patients had the Gln48His mutation in MYOC. There was no difference in the frequency of a MYOC -83G>A promoter polymorphism between patients and controls. A novel OPTN mutation, Thr202Arg, was detected in one of 251 (0.4%) patients. The OPTN variant Met98Lys was detected in similar frequencies in patients and controls. No mutation was detected in OPTC. Taken together, 3.59% (9/251) of our POAG patients had mutations in the CYP1B1, MYOC, and OPTN genes.
###end p 6
###begin title 7
Conclusions
###end title 7
###begin p 8
###xml 60 66 60 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 68 72 68 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 78 82 78 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 139 147 <span type="species:ncbi:9606">patients</span>
###xml 219 227 <span type="species:ncbi:9606">patients</span>
This is the first report to document the involvement of the CYP1B1, MYOC, and OPTN genes in the etiology of POAG in the same set of Indian patients. Our study shows that mutations in these genes are rare in Indian POAG patients.
###end p 8
###begin title 9
Introduction
###end title 9
###begin p 10
###xml 153 154 153 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 322 323 322 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 135 141 <span type="species:ncbi:9606">people</span>
Glaucoma is the leading cause of irreversible blindness and the second leading cause of blindness after cataract, affecting 66 million people worldwide [1]. Glaucoma is a heterogeneous group of progressive optic neuropathies characterized by an excavation of the optic disc and progressive alteration of the visual field [2]. High intraocular pressure (IOP), defined as being above 21 mmHg, in both eyes and a positive family history for glaucoma are commonly associated risk factors. Based on the age of onset and other clinical features, glaucoma has been classified into primary congenital glaucoma (PCG), juvenile-onset open-angle glaucoma (JOAG), and adult-onset primary open-angle glaucoma (POAG). PCG manifests at birth or in early infancy (up to 3 years of age). Its phenotype is characterized by elevated IOP, corneal edema, enlargement of the globe (buphthalmos), epiphora, photophobia, and blepharospasm. PCG occurs as a result of developmental anomalies of the anterior chamber angle that prevent drainage of the aqueous humor, thereby elevating IOP. PCG is most commonly inherited as an autosomal recessive trait. JOAG is characterized by early onset (at 10-35 years of age) and autosomal dominant inheritance with high penetrance. POAG occurs after the age of 35 years and is the most common form of glaucoma.
###end p 10
###begin p 11
###xml 376 377 376 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 378 380 378 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 409 413 409 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 414 418 414 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TIGR</italic>
###xml 420 426 420 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 428 432 428 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 438 443 438 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
###xml 474 475 474 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 476 478 476 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 479 481 479 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 558 562 558 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 563 567 563 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TIGR</italic>
###xml 686 688 686 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 712 718 712 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 822 823 822 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 824 826 824 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 827 829 827 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 859 863 859 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 915 921 915 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 988 994 988 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 1038 1042 1038 1042 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 1049 1051 1049 1051 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 1070 1074 1070 1074 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 1208 1210 1208 1210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 1250 1255 1250 1255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
###xml 1356 1357 1356 1357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
In a majority of cases, glaucoma does not follow a clear-cut inheritance pattern. However, clustering of multiple affected individuals within families suggests that it has a genetic basis. Linkage analyses have identified 23 loci (GLC1A-GLC1L, GLC3A-GLC3B, 2p14, 2q33-q34, 5q22.1-q32, 10p12-p13, 14q11, 14q21-q22, 17p13, 17q25, and 19q12-q14) for different forms of glaucoma [3-10]. However, only four genes (MYOC/TIGR, CYP1B1, OPTN, and WDR36) have been identified so far [4,11-13]. The myocilin/trabecular meshwork-induced glucocorticoid response protein (MYOC/TIGR) gene, located at the GLC1A locus on chromosome 1q24.3-q25.2, has been shown to cause glaucoma in 2-4% of POAG cases [14]. The cytochrome P450 (CYP1B1) gene, located at the GLC3A locus on chromosome 2p22-p21, has been shown to cause PCG, JOAG, and POAG [2,12,15]. In a large family in which MYOC-linked POAG segregated, a heterozygous mutation in CYP1B1 was associated with early onset of the disease, indicating that a CYP1B1 mutation might behave as a modifier of the MYOC gene [15]. The optineurin (OPTN) gene, located at the GLC1E locus on chromosome 10p14-p15, has been shown to cause normal tension glaucoma (NTG), a subtype of POAG [13]. The WD repeat-containing protein 36 (WDR36) gene, located at the GLC1G locus on chromosome 5q21.3-q22.1, has been shown to be mutated in POAG [4].
###end p 11
###begin p 12
###xml 268 272 268 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 274 276 274 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 277 279 277 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 282 288 282 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 290 292 290 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 299 303 299 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 305 307 305 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 308 310 308 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 479 481 479 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 607 613 607 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 615 619 615 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 625 629 625 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 722 728 722 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 730 734 730 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 740 744 740 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 349 357 <span type="species:ncbi:9606">patients</span>
###xml 662 670 <span type="species:ncbi:9606">patients</span>
###xml 770 778 <span type="species:ncbi:9606">patients</span>
Glaucoma is a treatable disease if detected early. Therefore, development of an accurate test for the detection of presymptomatic carriers at risk is important for the management of glaucoma. To this end, a few studies have been carried out to assess the roles of the MYOC [16-19], CYP1B1 [20], and OPTN [21,22] genes in the etiology of Indian POAG patients from different parts of the country. We have reported the genetic analysis of glaucoma in a large south Indian pedigree [18]. Moreover, there is no comprehensive study published to date that assesses the roles of three known glaucoma-causing genes (CYP1B1, MYOC, and OPTN) in the same set of Indian POAG patients. In this study, we report mutation analysis of the CYP1B1, MYOC, and OPTN genes in 251 Indian POAG patients from the south Indian state of Karnataka.
###end p 12
###begin p 13
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTC</italic>
###xml 224 226 224 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 395 397 395 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 408 412 408 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTC</italic>
###xml 530 534 530 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTC</italic>
The OPTC (opticin) gene encodes a protein that is a member of the small leucine-rich repeat protein (SLRP) family, and is located on chromosome 1q31-q32 within an age-related macular degeneration (AMD) susceptibility locus [23]. Because of its protein profile in different parts of the eye, such as the iris, trabecular meshwork/ciliary body, retina, vitreous, and optic nerve, Friedman et al. [23] screened OPTC for mutations in individuals with POAG, NTG, and AMD. They failed to find any mutation in this gene. To rule out the OPTC gene as a glaucoma gene, we screened this gene in our POAG data set. The results of our analysis are presented herein.
###end p 13
###begin title 14
Methods
###end title 14
###begin title 15
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients
###end title 15
###begin p 16
###xml 15 23 <span type="species:ncbi:9606">patients</span>
###xml 114 119 <span type="species:ncbi:9689">Lions</span>
###xml 217 225 <span type="species:ncbi:9606">patients</span>
###xml 348 356 <span type="species:ncbi:9606">patients</span>
###xml 362 370 <span type="species:ncbi:9606">patients</span>
###xml 520 528 <span type="species:ncbi:9606">patients</span>
###xml 666 674 <span type="species:ncbi:9606">patients</span>
###xml 745 753 <span type="species:ncbi:9606">patients</span>
###xml 772 780 <span type="species:ncbi:9606">patients</span>
###xml 901 909 <span type="species:ncbi:9606">patients</span>
###xml 1016 1024 <span type="species:ncbi:9606">Patients</span>
###xml 1304 1316 <span type="species:ncbi:9606">participants</span>
###xml 1538 1545 <span type="species:ncbi:9606">patient</span>
A total of 251 patients with adult-onset POAG were evaluated at the Minto Ophthalmic Hospital, and Bangalore West Lions Superspecialty Eye Hospital. Both hospitals are located in the city of Bangalore, Karnataka. The patients were natives of Karnataka and spoke the south Indian Kannada language. They ranged in age from 45 to 65 years. Of the 251 patients, 116 patients received the diagnosis of POAG based on the presence of characteristic glaucomatous optic neuropathy and defects in visual fields. The remaining 135 patients were given the diagnosis of glaucoma based on glaucomatous optic neuropathy only, as visual field defects could not be assessed in these patients due to an advance stage of glaucoma. IOP was more than 21 mmHg in 198 patients. The remaining 53 patients had NTG with IOP below 21 mmHg and significant optic disc damage and visual field defects at the time of diagnosis. All patients had open-angles (Shafer grade greater than III) on gonioscopy and no other eye or systemic abnormalities. Patients with secondary causes of glaucoma (e.g., uveitis, steroid-induced, or trauma) were excluded from this study. We recruited 100 normal controls, also from Karnataka and with the same linguistic background, through several eye care camps. Their ages ranged from 45 to 75 years. All participants went through a detailed clinical examination and were found to have no signs or symptoms of glaucoma or any other eye disease. Controls did not have any family history of glaucoma. Informed consent was obtained from each patient. This study followed the guidelines of the Indian Council of Medical Research, New Delhi.
###end p 16
###begin title 17
Molecular study
###end title 17
###begin p 18
###xml 90 92 90 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
###xml 485 491 483 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 493 497 491 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 499 503 497 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 509 513 507 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTC</italic>
###xml 627 633 625 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 635 639 633 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 641 645 639 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 651 655 649 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTC</italic>
###xml 795 802 793 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 826 831 824 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">WDR36</italic>
###xml 872 874 870 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 1142 1144 1138 1140 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1228 1231 1224 1227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq</italic>
###xml 1263 1265 1259 1261 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
###xml 1823 1825 1789 1791 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1905 1907 1871 1873 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
###xml 2079 2083 2045 2049 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 2131 2133 2097 2099 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 2777 2781 2743 2747 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 3106 3112 3072 3078 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 3211 3217 3177 3183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 3256 3262 3222 3228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 3340 3346 3306 3312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 3377 3383 3343 3349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 2687 2694 <span type="species:ncbi:9606">patient</span>
###xml 3127 3135 <span type="species:ncbi:9606">patients</span>
Three to five ml of peripheral blood was collected from each individual in Vacutainer EDTATM tubes (Beckton-Dickinson, Franklin Lakes, NJ). Genomic DNA was isolated from blood samples using a Wizard(R) genomic DNA extraction kit (Promega, Madison, WI). Mutation analyses of the four genes were carried out using a combination of PCR-SSCP (polymerase chain reaction-single strand conformation polymorphism) and DNA sequencing techniques. For PCR-SSCP, primer sets were designed for the CYP1B1, MYOC, OPTN, and OPTC genes, which covered their entire coding regions and intron-exon junctions. The reference mRNA sequences for the CYP1B1, MYOC, OPTN, and OPTC genes used were , , , and , respectively. The genomic sequences for these genes were retrieved from the  site. Primer details are shown in Table 1 Since abnormalities in WDR36 alone are not sufficient to cause POAG [24], we have not screened this gene for mutations in our POAG samples. In the future, we plan to screen this gene for mutations in our samples. PCR was carried out in a 25 mul reaction volume containing 50-100 ng of genomic DNA, 50 ng of each primer, 0.25 mul of alpha P32-dCTP (3,000 Ci/mmole; PerkinElmer, Wellesley, MA), 0.2 mM of each dNTP, and 1 U of Taq DNA polymerase (Bangalore GeneiTM, Bangalore, India) in a standard buffer supplied by the vendor. PCR was carried out in a Thermal Cycler PTC150 (MJ Research, Watertown, MA) under the following conditions: an initial denaturation at 95 degreesC for 2 min was followed by 35 cycles at 95 degreesC for 30 s, 55-72 degreesC for 30 s, 72 degreesC for 1 min with a final extension at 72 degreesC for 5 min. Following PCR-SSCP, the gels were dried and subjected to Phosphor Image analysis (Fuji, Kanagawa, Japan). For sequencing, PCR was carried out as aforedescribed but without including alpha P32-dCTP in the reaction mixture. PCR amplified products were purified using AuprepTM PCR Purification Columns (Invitrogen, Delhi, India) and sequenced on an ABI PRISM A310 automated sequencer (PE Biosystems, Foster City, CA). Since we did not identify the MYOC Gln48His mutation reported from India earlier [19] in our samples by PCR-SSCP analysis, we used allele-specific PCR to screen the samples for the presence of this mutation. The sequence of the common forward primer for allele-specific PCR is as follows: 5'-TGC AAT GAG GTT CTT CTG TGC ACG-3'. The sequences of the reverse allele-specific primers are as follows: 5'(mutant allele)-GAC TGG CCA CAC TGA AGG TAT AA-3' and 5'(wild-type allele)-GAC TGG CCA CAC TGA AGG TAT AC-3'. A 190 bp amplicon was generated with common forward and wild-type/mutant allele primers. Following detection of this mutation in patient samples, PCR products were sequenced to confirm the presence of the mutation. The MYOC-83G>A promoter polymorphism was studied by PCR-SSCP analysis. Primer sequences for this polymorphism are as follows: forward 5'-CAG CCT CAC GTG GCC ACC TCT GTC-3' and reverse 5'-AGG CCC AAA GCT GCA GCA ACG TGC-3'. These primers amplify a 196 bp amplicon. In order to see whether there could be a common origin of a specific CYP1B1 mutation, all patients with the mutation were genotyped with four microsatellite markers from the CYP1B1 candidate region and three intragenic CYP1B1 single nucleotide polymorphisms (SNPs). The order of markers with respect to CYP1B1 is as follows: D2S177-D2S1346-CYP1B1-D2S2974-D2S2331 (taken from the  site).
###end p 18
###begin title 19
###xml 60 66 60 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 68 72 68 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 74 78 74 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 84 88 84 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTC</italic>
Details of primer sets used in the PCR-SSCP analysis of the CYP1B1, MYOC, OPTN, and OPTC genes.
###end title 19
###begin p 20
###xml 368 374 368 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 397 401 397 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 417 421 417 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTC</italic>
Note that primer sets CY2AF/CY2AR, OPTN4aF/OPTN4aR, and OPTN7F/OPTN7R work with 5% DMSO and 1.5 mM magnesium chloride. Primer sets CY2BF/CY2BR, CY2CF/CY2CR, CY2DF/CY2DR, and CY2EF/CY2ER work with 5% DMSO and 1 mM magnesium chloride. Primer set TG1BF/TG1DBR works with 1 mM magnesium chloride. The rest of the primer sets work with 1.5 mM magnesium chloride. Exon 1 of CYP1B1, exons 1, 2, and 3 of OPTN, and exon 1 of OPTC were not screened for mutations as they are non-coding. AT, annealing temperature.
###end p 20
###begin title 21
Results & Discussion
###end title 21
###begin p 22
###xml 44 50 44 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 225 232 225 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 360 362 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
###xml 542 551 542 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1A</xref>
###xml 720 727 720 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 837 844 837 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 861 862 861 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 948 954 948 954 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 1038 1040 1038 1040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
###xml 1158 1160 1158 1160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 1274 1280 1274 1280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 1429 1431 1429 1431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 64 72 <span type="species:ncbi:9606">patients</span>
###xml 215 223 <span type="species:ncbi:9606">patients</span>
###xml 323 331 <span type="species:ncbi:9606">patients</span>
###xml 527 532 <span type="species:ncbi:9606">human</span>
###xml 536 540 <span type="species:ncbi:7962">carp</span>
###xml 609 617 <span type="species:ncbi:9606">patients</span>
###xml 744 752 <span type="species:ncbi:9606">patients</span>
###xml 899 907 <span type="species:ncbi:9606">patients</span>
###xml 1080 1088 <span type="species:ncbi:9606">patients</span>
###xml 1192 1200 <span type="species:ncbi:9606">patients</span>
Analysis of the entire coding region of the CYP1B1 gene in POAG patients revealed four different mutations (c.578C>T/Pro193Leu, c.685G>A/Glu229Lys, c.875T>A/Met292Lys, and c.1103G>A/Arg368His) in 10.76% (27/251) of patients (Table 2). Three mutations; Pro193Leu, Glu229Lys, and Arg368His, have been reported earlier in PCG patients from different populations [25-27]. The fourth mutation, Met292Lys, is a novel one in exon 2 and fulfills the criteria of a mutation since the methionine residue is conserved across species from human to carp (Figure 1A) and was not found in 97 controls (data not shown). Only patients 119 and 179 were compound heterozygous for Met292Lys/Arg368His and Pro193Leu/Glu229Lys, respectively (Table 2). The remaining patients were heterozygous for the Pro193Leu, Glu229Lys, Met292Lys, and Arg368His mutations (Table 2). Melki et al. [2] found that 4.6% (11/236) of French patients with early-onset POAG have mutations in CYP1B1. They have reported the Glu229Lys mutation in a heterozygous state. Colomb et al. [27] found that 6.45% (2/31) of French PCG patients have the Glu229Lys mutation in a heterozygous state. Acharya et al. [20] observed that 4.5% (9/200) of patients with JOAG from the eastern Indian state of West Bengal have mutations in CYP1B1. The Glu229Lys and Arg368His mutations were found in a heterozygous state, and these mutations were not present in 100 ethnically matched controls [20].
###end p 22
###begin title 23
###xml 53 59 53 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 61 65 61 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 71 75 71 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 113 121 <span type="species:ncbi:9606">patients</span>
Previously known and novel mutations detected in the CYP1B1, MYOC, and OPTN genes in primary open-angle glaucoma patients.
###end title 23
###begin p 24
###xml 117 123 117 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 125 129 125 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 135 139 135 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 59 67 <span type="species:ncbi:9606">patients</span>
###xml 378 386 <span type="species:ncbi:9606">patients</span>
Shown are details of 30 primary open-angle glaucoma (POAG) patients with previously known and novel mutations in the CYP1B1, MYOC, and OPTN genes. Since the Glu229Lys and Arg368His mutations were found in normal controls with frequencies of 5% and 2%, respectively, these mutations might be polymorphic variants in our population. By excluding these mutations, the frequency of patients with mutations in three glaucoma-causing genes is 3.59% (9/251). In the table, * indicates a novel mutation; + identifies wild-type alleles; # indicates a family history of glaucoma; other cases are sporadic. The following abbreviations were used: normal tension glaucoma (NTG), right eye (RE), left eye (LE), both eyes (BE), perception of light negative (PL-ve), and cup to disc (CD). The age of onset and diagnosis are in years.
###end p 24
###begin p 25
###xml 25 31 25 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 36 40 36 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 48 49 48 49 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 174 180 174 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 263 264 263 264 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 391 395 391 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 103 110 <span type="species:ncbi:9606">patient</span>
###xml 321 328 <span type="species:ncbi:9606">patient</span>
Mutation analysis of the CYP1B1 and OPTN genes. A: The left panel shows a sequencing chromatogram from patient 119 who had a novel mutation c.875T>A (Met292Lys) in exon 2 of CYP1B1, and the right panel shows conservation of the methionine residue across species. B: The left panel presents a sequencing chromatogram from patient 30 who had a novel mutation c.915C>G (Thr202Arg) in exon 7 of OPTN, and the right panel shows conservation of the threonine residue across species. Arrows mark positions of nucleotide changes and conserved amino acid residues.
###end p 25
###begin p 26
###xml 16 18 16 18 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 91 95 91 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 324 331 324 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 735 736 735 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 961 963 961 963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 1042 1048 1042 1048 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 1146 1148 1146 1148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 1417 1423 1417 1423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 1462 1468 1462 1468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 1579 1586 1579 1586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 1647 1654 1647 1654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t3">Table 3</xref>
###xml 186 194 <span type="species:ncbi:9606">patients</span>
###xml 229 237 <span type="species:ncbi:9606">patients</span>
###xml 279 287 <span type="species:ncbi:9606">patients</span>
###xml 884 892 <span type="species:ncbi:9606">patients</span>
###xml 1303 1311 <span type="species:ncbi:9606">patients</span>
###xml 1344 1352 <span type="species:ncbi:9606">patients</span>
###xml 1523 1531 <span type="species:ncbi:9606">patients</span>
Vincent et al. [15] reported the Arg368His mutation in a heterozygous state along with the MYOC Gly399Val mutation in an east Indian/Guyanese family with early-onset glaucoma. Of 30/251 patients with mutations in our samples, 13 patients (5.2%) had the Glu229Lys mutation and 10 patients (3.98%) had the Arg308His mutation (Table 2). In order to see whether these mutations were present in normal controls, we screened 100 normal controls. The Glu229Lys and Arg368 mutations were found with frequencies of 5% and 2%, respectively, in normal controls (data not shown), suggesting that these mutations might be polymorphic variants in our population. The presence of the Arg368His mutation in controls is not surprising as Melki et al. [2] discovered 2.13% (1/47) of French controls with this mutation. The Glu229Lys and Arg368His mutations were the most common mutations in Indian PCG patients with frequencies of 16.22% (6/37) and 59.46% (22/37), respectively [28]. However, ethnically matched population screening of 140 chromosomes for the CYP1B1 mutations showed 6.4% and 0.7% carriers for the Glu229Lys and Arg368His mutations, respectively [28]. The other known mutation, Pro193Leu, was not present in 100 normal controls (data not shown). In order to determine whether the Glu229Lys variant in 13 patients could have a common origin, all patients were genotyped with four microsatellite markers (D2S177-D2S1346-CYP1B1-D2S2974-D2S2331) and three intragenic CYP1B1 SNPs. An absence of allele sharing for the markers in patients suggested that Glu229Lys has multiple origins (Table 3). A similar result was obtained for the Arg368His mutation (Table 3).
###end p 26
###begin title 27
###xml 54 60 54 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 99 105 99 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 141 149 <span type="species:ncbi:9606">patients</span>
Genotypes at four microsatellite markers flanking the CYP1B1 candidate region and three intragenic CYP1B1 single nucleotide polymorphisms in patients with Glu229Lys and Arg368His variants
###end title 27
###begin p 28
###xml 146 154 <span type="species:ncbi:9606">patients</span>
###xml 219 227 <span type="species:ncbi:9606">patients</span>
###xml 408 416 <span type="species:ncbi:9606">patients</span>
###xml 473 481 <span type="species:ncbi:9606">patients</span>
Each number under a microsatellite marker column represents an allele. As can be seen from the genotypes at four microsatellite marker loci, some patients with either of the variants did not share alleles. For example, patients 168 and 179 with Glu229Lys did not share alleles at D2S177, D2S1346, and D2S2331. Although single nucleotide polymorphisms (SNPs) are less polymorphic than microsatellite markers, patients 54 and 73 did not share alleles at c.142C>G. Similarly, patients 7 and 38 with Arg368His did not share alleles at D2S177, D2S1346, and D2S2331. However, alleles at three SNP loci were not useful to determine nonsharing of alleles for Arg368His. Overall, the results suggest multiple origins for both variants.
###end p 28
###begin p 29
###xml 31 37 31 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 139 146 139 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
###xml 299 306 299 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
###xml 447 454 447 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
###xml 709 716 709 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t5">Table 5</xref>
###xml 719 721 719 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 589 597 <span type="species:ncbi:9606">patients</span>
###xml 637 645 <span type="species:ncbi:9606">patients</span>
In addition to mutations, nine CYP1B1 population variants and polymorphisms were also identified in our samples, including two novel SNPs (Table 4). It is interesting to note that c.142C>G (Arg48Gly) and c.355G>T (Ala119Ser) occurred at a high frequency and were in complete linkage disequilibrium (Table 4). Similarly, c.1294G>C (Val432Leu) and c.1347T>C (Asp449Asp) also occurred at a high frequency and were in complete linkage disequilibrium (Table 4). Interestingly, c.142C>G (Arg48Gly) and c.355G>T (Ala119Ser) always occurred with c.1294G>C (Val432Leu) and c.1347T>C (Asp449Asp) in patients. Similar results were obtained in JOAG patients and normal controls from the east Indian state of West Bengal (Table 5) [20]. The significance of this phenomenon is not clear at present.
###end p 29
###begin title 30
###xml 54 60 54 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 62 66 62 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 68 72 68 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 78 82 78 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTC</italic>
###xml 120 128 <span type="species:ncbi:9606">patients</span>
Polymorphisms and population variants observed in the CYP1B1, MYOC, OPTN, and OPTC genes in primary open-angle glaucoma patients and controls
###end title 30
###begin p 31
###xml 74 80 74 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 82 86 82 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 88 92 88 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 98 102 98 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTC</italic>
###xml 152 160 <span type="species:ncbi:9606">patients</span>
###xml 374 382 <span type="species:ncbi:9606">patients</span>
###xml 438 446 <span type="species:ncbi:9606">patients</span>
Shown are the frequencies of polymorphisms and population variants in the CYP1B1, MYOC, OPTN, and OPTC genes seen in primary open-angle glaucoma (POAG) patients and controls. In the table, * indicates a risk factor, ** notes a novel single nucleotide polymorphism (SNP), and # highlights two polymorphisms, -83G>A and Arg76Lys, that were detected in high frequencies in 116 patients and thus were not screened in the remainder of the 251 patients.
###end p 31
###begin title 32
###xml 75 81 75 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 83 87 83 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 89 93 89 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 99 103 99 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTC</italic>
###xml 141 149 <span type="species:ncbi:9606">patients</span>
Reported frequencies of known polymorphisms and population variants in the CYP1B1, MYOC, OPTN, and OPTC genes in primary open-angle glaucoma patients and controls from different populations
###end title 32
###begin p 33
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 78 86 78 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC.mt1</italic>
###xml 172 174 172 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r43">43</xref>
###xml 194 196 194 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r44">44</xref>
###xml 276 284 <span type="species:ncbi:9606">patients</span>
###xml 304 310 <span type="species:ncbi:9103">Turkey</span>
We did not look for another MYOC promoter polymorphism at nt -1000 (-1000C>G; MYOC.mt1; asterisk) in our primary open-angle glaucoma (POAG) data set because Alward et al. [43] and Ozgul et al. [44] have observed that it is not a risk factor for the development of glaucoma in patients from the U.S.A. or Turkey, respectively.
###end p 33
###begin p 34
###xml 16 20 16 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 341 343 341 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 413 415 413 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 613 615 613 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 644 648 644 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 711 713 711 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 736 738 736 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 848 852 848 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 889 891 889 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 978 982 978 982 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 53 61 <span type="species:ncbi:9606">patients</span>
###xml 290 298 <span type="species:ncbi:9606">patients</span>
###xml 403 411 <span type="species:ncbi:9606">patients</span>
###xml 570 577 <span type="species:ncbi:9606">patient</span>
###xml 763 771 <span type="species:ncbi:9606">patients</span>
###xml 947 955 <span type="species:ncbi:9606">patients</span>
Analysis of the MYOC gene revealed that 2/251 (0.8%) patients had the Gln48His mutation in a heterozygous state. This mutation was not present in 100 normal controls (data not shown). No other mutation was detected in our samples. The Gln48His mutation has been detected in 4/200 (2%) POAG patients in a heterozygous state from West Bengal [19]. This mutation has also been detected in 5/200 (2.5%) PCG patients [19]. Previously, we detected a novel Pro274Arg mutation in a four-generation family with members affected with JOAG and POAG, and with one severely affected patient being homozygous for the mutation [18]. Overall, the frequency of MYOC mutations has been found to be 2-4% in different populations [14]. Kanagavalli et al. [17] noted 1.87% (2/107) of patients with POAG from the south Indian state of Tamilnadu who had mutations in the MYOC gene. However, Mukhopadhyay et al. [16] discovered a higher frequency (7.14% or 4/56) of POAG patients from West Bengal with MYOC mutations. This could be a statistical anomaly due to a small sample size or a true pattern representative of different geographic origins.
###end p 34
###begin p 35
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 89 91 89 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 92 94 92 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r29">29</xref>
###xml 96 103 96 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t5">Table 5</xref>
###xml 181 183 181 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r30">30</xref>
###xml 184 186 184 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r31">31</xref>
###xml 204 206 204 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r29">29</xref>
###xml 549 556 549 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
###xml 638 640 638 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 739 746 739 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
###xml 751 758 751 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t5">Table 5</xref>
###xml 917 921 917 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 373 380 <span type="species:ncbi:9606">patient</span>
###xml 716 724 <span type="species:ncbi:9606">patients</span>
The MYOC promoter polymorphism at -83G>A was initially reported from Western countries ([14,29] Table 5). This polymorphism has been also observed in Hong Kong and the Philippines [30,31]. Alward et al. [29] suggested that it is unlikely to be a disease-causing mutation. Since this polymorphism was detected in many countries, we wanted to determine its prevalence in our patient and control samples. We did not find any significant difference in the frequency of -83G>A between POAG samples and controls (76.72% in POAG versus 76.53% in controls; Table 4). This is similar to the earlier report from West Bengal by Mukhopadhyay et al. [16]. Interestingly, -83G>A is in linkage disequilibrium with Arg76Lys both in patients and controls (Table 4 and Table 5), suggesting that the -83G>A polymorphism is not a risk factor for developing glaucoma in Indians. Taken together, our observations suggest that mutations in MYOC gene may not be a major factor in the appearance of the POAG phenotype in India.
###end p 35
###begin p 36
###xml 32 36 32 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 147 156 147 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1B</xref>
###xml 158 165 158 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t2">Table 2</xref>
###xml 350 359 350 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1B</xref>
###xml 379 381 379 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 405 409 405 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 551 553 551 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 753 755 753 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r32">32</xref>
###xml 756 758 756 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r36">36</xref>
###xml 804 808 804 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 995 999 995 999 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 1085 1087 1085 1087 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 1088 1090 1088 1090 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 1091 1093 1091 1093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r32">32</xref>
###xml 1094 1096 1094 1096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r36">36</xref>
###xml 1192 1194 1192 1194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 1290 1292 1290 1292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r37">37</xref>
###xml 1310 1312 1310 1312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r38">38</xref>
###xml 1478 1482 1478 1482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 60 67 <span type="species:ncbi:9606">patient</span>
###xml 318 323 <span type="species:ncbi:9606">human</span>
###xml 334 339 <span type="species:ncbi:10090">mouse</span>
###xml 345 348 <span type="species:ncbi:10116">rat</span>
###xml 444 452 <span type="species:ncbi:9606">patients</span>
###xml 631 639 <span type="species:ncbi:9606">patients</span>
###xml 836 844 <span type="species:ncbi:9606">patients</span>
###xml 1076 1083 <span type="species:ncbi:9606">patient</span>
###xml 1259 1267 <span type="species:ncbi:9606">patients</span>
Mutation analysis of the entire OPTN gene revealed that one patient (0.40%) was heterozygous for a novel mutation, Thr202Arg (c.915C>G) in exon 7 (Figure 1B, Table 2). This mutation fulfills the criteria of a mutation because it is not present in 93 controls (data not shown) and the threonine residue is conserved in human, macaque, mouse, and rat (Figure 1B). Sripriya et al. [22] recently screened the OPTN gene in 100 high tension glaucoma patients from another south Indian state, Tamilnadu, and did not detect any mutation. Mukhopadhyay et al. [21] screened the entire coding region of this gene and detected 6/200 (3%) POAG patients from West Bengal, who were heterozygous for the Arg545Gln mutation in exon 16. As observed in other populations [32-36], the present observation also suggests that OPTN mutations are rare in POAG patients. A total of eight mutations (Glu50Lys, c.691-692insAG, Arg545Gln, Ala336Gly, Ala377Thr, His26Asp, His486Arg, and Glu104Asp) have been reported in the OPTN gene from different populations, including the His486Arg mutation in a JOAG patient [13,21,32-36]. Interestingly, one of the three mutations, Arg545Gln (c.1944G>A), reported by Rezaie et al. [13], has been detected in similar frequencies in Japanese glaucoma patients and control subjects [37]. Alward et al. [38] commented that the Arg545Gln variation is likely to be a nondisease-causing polymorphism. With the Thr202Arg mutation identified in this study, the total number of OPTN mutations, excluding Arg545Gln, reaches eight.
###end p 36
###begin p 37
###xml 15 17 15 17 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 301 303 301 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r38">38</xref>
###xml 322 324 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r33">33</xref>
###xml 443 445 443 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r37">37</xref>
###xml 638 640 638 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r35">35</xref>
###xml 641 643 641 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r39">39</xref>
###xml 663 665 663 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 895 897 895 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 941 943 941 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 1071 1073 1071 1073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 1142 1144 1142 1144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 1325 1332 1325 1332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
###xml 401 409 <span type="species:ncbi:9606">patients</span>
###xml 506 514 <span type="species:ncbi:9606">patients</span>
###xml 628 636 <span type="species:ncbi:9606">patients</span>
###xml 771 779 <span type="species:ncbi:9606">patients</span>
###xml 1103 1111 <span type="species:ncbi:9606">patients</span>
###xml 1171 1179 <span type="species:ncbi:9606">patients</span>
Rezaie et al. [13] initially reported that Met98Lys (c.603T>A) is a risk-associated alteration (risk factor) for developing glaucoma. They found this variant in both affected individuals and controls, but it was more common in affected individuals than in controls (13.6% versus 2.1%). Alward et al. [38] and Fuse et al. [33] showed a significant association between Met98Lys and glaucoma in Japanese patients. On the other hand, Toda et al. [37] found similar frequencies of Met98Lys in Japanese glaucoma patients and controls. Interestingly, Met98Lys has been shown to be a polymorphic variant in German, French, and Moroccan patients [35,39]. Sripriya et al. [22] did not detect Met98Lys in 100 controls, although it was present in 7/170 (4.1%) POAG and 3/50 (6%) NTG patients from Tamilnadu. However, a statistical analysis did not show any significant correlation with clinical parameters [22]. In another study by Mukhopadhyay et al. [21], the frequency of Met98Lys was found to be 11% and 5.5% in POAG and controls from West Bengal, respectively. Sripriya et al. [22] found Met98Lys in 6% of NTG patients, whereas Mukhopadhyay et al. [21] failed to find it in NTG patients. In our dataset, the frequency of this variant was found to be similar in our POAG samples and controls (7.97% in POAG versus 7.29% in controls; Table 4), suggesting that it may not be a risk factor for developing glaucoma in Indian populations.
###end p 37
###begin p 38
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTC</italic>
###xml 101 105 101 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTC</italic>
###xml 161 163 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 225 227 225 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 299 306 299 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t5">Table 5</xref>
###xml 359 366 359 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
###xml 443 445 443 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 476 483 476 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t5">Table 5</xref>
###xml 542 549 542 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t4">Table 4</xref>
###xml 256 264 <span type="species:ncbi:9606">patients</span>
Mutation analysis of the OPTC gene did not detect any mutation in our POAG samples. Screening of the OPTC gene was carried out in POAG cases by Friedman et al. [23]. The Leu268Pro polymorphism, identified by Friedman et al. [23] in 6/87 (6.9%) of POAG/NTG patients and in 8/55 (14.55%) of controls (Table 5), was found in 31/251 (12.35%) of our POAG samples (Table 4). Another synonymous codon change Leu270Leu, identified by Friedman et al. [23] in 2/55 (3.66%) of controls (Table 5), was also detected in 5/251 (1.99%) of our POAG samples (Table 4).
###end p 38
###begin p 39
###xml 68 74 68 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 76 80 76 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 86 90 86 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 119 125 119 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 343 349 343 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CYP1B1</italic>
###xml 402 403 402 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 518 520 518 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r40">40</xref>
###xml 560 564 560 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 609 613 609 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MYOC</italic>
###xml 618 622 618 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPTN</italic>
###xml 38 46 <span type="species:ncbi:9606">patients</span>
###xml 204 212 <span type="species:ncbi:9606">patients</span>
###xml 415 423 <span type="species:ncbi:9606">patients</span>
###xml 647 655 <span type="species:ncbi:9606">patients</span>
###xml 784 792 <span type="species:ncbi:9606">patients</span>
###xml 867 875 <span type="species:ncbi:9606">patients</span>
In summary, 3.59% (9/251) of our POAG patients had mutations in the CYP1B1, MYOC, and OPTN genes. Two previously known CYP1B1 mutations, Glu229Lys and Arg368His, were found in similar frequencies in POAG patients and controls, suggesting that these mutations might be polymorphic variants in our population. A similar situation exists for the CYP1B1 Ala443Gly mutation, first reported by Melki et al. [2] in French patients, and was found to be a polymorphic variant in an Ethiopian population with a frequency of 7% [40]. No association was found between the OPTN Met98Lys variant and glaucoma. Mutations in MYOC and OPTN are rare in Indian POAG patients. This is the first study to document the prevalence of mutations in three glaucoma-causing genes in the same set of Indian POAG patients. Our study suggests that mutations in these genes are rare in Indian POAG patients.
###end p 39
###begin title 40
Acknowledgements
###end title 40
###begin p 41
###xml 13 21 <span type="species:ncbi:9606">patients</span>
###xml 301 308 <span type="species:ncbi:9606">patient</span>
We thank the patients, their family members, and our controls for participating in this study. This study was supported by a grant from the Council of Scientific and Industrial Research, New Delhi. We thank Ms. S. Bhattacharjee for technical help and Dr. V. Meera and Dr. N. Savitha for their help in patient recruitment. We thank Prof. V. Nanjundiah for reading the manuscript and for valuable advice. Finally, we also thank two anonymous reviewers for their valuable suggestions to improve the manuscript.
###end p 41
###begin title 42
References
###end title 42
###begin article-title 43
###xml 10 16 <span type="species:ncbi:9606">people</span>
Number of people with glaucoma worldwide.
###end article-title 43
###begin article-title 44
###xml 27 35 <span type="species:ncbi:9606">patients</span>
CYP1B1 mutations in French patients with early-onset primary open-angle glaucoma.
###end article-title 44
###begin article-title 45
Progress in the genetics of glaucoma.
###end article-title 45
###begin article-title 46
Identification of a novel adult-onset primary open-angle glaucoma (POAG) gene on 5q22.1.
###end article-title 46
###begin article-title 47
Early adult-onset POAG linked to 15q11-13 using ordered subset analysis.
###end article-title 47
###begin article-title 48
A genomewide scan identifies novel early-onset primary open-angle glaucoma loci on 9q22 and 20p12.
###end article-title 48
###begin article-title 49
Evidence for a novel glaucoma locus at chromosome 3p21-22.
###end article-title 49
###begin article-title 50
A genome-wide scan maps a novel juvenile-onset primary open-angle glaucoma locus to 15q.
###end article-title 50
###begin article-title 51
A genome-wide scan maps a novel juvenile-onset primary open angle glaucoma locus to chromosome 5q.
###end article-title 51
###begin article-title 52
Gene mapping for primary open angle glaucoma.
###end article-title 52
###begin article-title 53
Identification of a gene that causes primary open angle glaucoma.
###end article-title 53
###begin article-title 54
Identification of three different truncating mutations in cytochrome P4501B1 (CYP1B1) as the principal cause of primary congenital glaucoma (Buphthalmos) in families linked to the GLC3A locus on chromosome 2p21.
###end article-title 54
###begin article-title 55
Adult-onset primary open-angle glaucoma caused by mutations in optineurin.
###end article-title 55
###begin article-title 56
###xml 48 56 <span type="species:ncbi:9606">patients</span>
Analysis of myocilin mutations in 1703 glaucoma patients from five different populations.
###end article-title 56
###begin article-title 57
Digenic inheritance of early-onset glaucoma: CYP1B1, a potential modifier gene.
###end article-title 57
###begin article-title 58
###xml 61 69 <span type="species:ncbi:9606">patients</span>
Mutations in MYOC gene of Indian primary open angle glaucoma patients.
###end article-title 58
###begin article-title 59
###xml 89 97 <span type="species:ncbi:9606">patients</span>
Evaluation and understanding of myocilin mutations in Indian primary open angle glaucoma patients.
###end article-title 59
###begin article-title 60
Genetic analysis of an Indian family with members affected with juvenile-onset primary open-angle glaucoma.
###end article-title 60
###begin article-title 61
Gln48His is the prevalent myocilin mutation in primary open angle and primary congenital glaucoma phenotypes in India.
###end article-title 61
###begin article-title 62
###xml 53 61 <span type="species:ncbi:9606">patients</span>
Primary role of CYP1B1 in Indian juvenile-onset POAG patients.
###end article-title 62
###begin article-title 63
###xml 55 63 <span type="species:ncbi:9606">patients</span>
Evaluation of Optineurin as a candidate gene in Indian patients with primary open angle glaucoma.
###end article-title 63
###begin article-title 64
###xml 22 30 <span type="species:ncbi:9606">patients</span>
OPTN gene: profile of patients with glaucoma from India.
###end article-title 64
###begin article-title 65
###xml 28 33 <span type="species:ncbi:9606">human</span>
Protein localization in the human eye and genetic screen of opticin.
###end article-title 65
###begin article-title 66
###xml 47 55 <span type="species:ncbi:9606">patients</span>
Distribution of WDR36 DNA sequence variants in patients with primary open-angle glaucoma.
###end article-title 66
###begin article-title 67
Multiple CYP1B1 mutations and incomplete penetrance in an inbred population segregating primary congenital glaucoma suggest frequent de novo events and a dominant modifier locus.
###end article-title 67
###begin article-title 68
Identification of novel mutations causing familial primary congenital glaucoma in Indian pedigrees.
###end article-title 68
###begin article-title 69
###xml 48 56 <span type="species:ncbi:9606">patients</span>
Novel cytochrome P450 1B1 (CYP1B1) mutations in patients with primary congenital glaucoma in France.
###end article-title 69
###begin article-title 70
###xml 101 109 <span type="species:ncbi:9606">patients</span>
Identification of R368H as a predominant CYP1B1 allele causing primary congenital glaucoma in Indian patients.
###end article-title 70
###begin article-title 71
Clinical features associated with mutations in the chromosome 1 open-angle glaucoma gene (GLC1A).
###end article-title 71
###begin article-title 72
###xml 84 92 <span type="species:ncbi:9606">patients</span>
Single nucleotide polymorphisms of the myocilin gene in primary open-angle glaucoma patients.
###end article-title 72
###begin article-title 73
Absence of myocilin and optineurin mutations in a large Philippine family with juvenile onset primary open angle glaucoma.
###end article-title 73
###begin article-title 74
###xml 109 117 <span type="species:ncbi:9606">patients</span>
Variants in optineurin gene and their association with tumor necrosis factor-alpha polymorphisms in Japanese patients with glaucoma.
###end article-title 74
###begin article-title 75
Molecular genetic analysis of optineurin gene for primary open-angle and normal tension glaucoma in the Japanese population.
###end article-title 75
###begin article-title 76
Variation in optineurin (OPTN) allele frequencies between and within populations.
###end article-title 76
###begin article-title 77
###xml 90 98 <span type="species:ncbi:9606">patients</span>
Prevalence of myocilin and optineurin sequence variants in German normal tension glaucoma patients.
###end article-title 77
###begin article-title 78
Different optineurin mutation pattern in primary open-angle glaucoma.
###end article-title 78
###begin article-title 79
###xml 45 53 <span type="species:ncbi:9606">patients</span>
Mutations in the optineurin gene in Japanese patients with primary open-angle glaucoma and normal tension glaucoma.
###end article-title 79
###begin article-title 80
###xml 54 62 <span type="species:ncbi:9606">patients</span>
Evaluation of optineurin sequence variations in 1,048 patients with open-angle glaucoma.
###end article-title 80
###begin article-title 81
###xml 88 96 <span type="species:ncbi:9606">patients</span>
The M98K variant of the OPTINEURIN (OPTN) gene modifies initial intraocular pressure in patients with primary open angle glaucoma.
###end article-title 81
###begin article-title 82
Functional analysis of six different polymorphic CYP1B1 enzyme variants found in an Ethiopian population.
###end article-title 82
###begin article-title 83
###xml 48 56 <span type="species:ncbi:9606">patients</span>
Promoter mutations of myocilin gene in Japanese patients with open angle glaucoma including normal tension glaucoma.
###end article-title 83
###begin article-title 84
Defining the pathogenicity of optineurin in juvenile open-angle glaucoma.
###end article-title 84
###begin article-title 85
###xml 35 43 <span type="species:ncbi:9606">patients</span>
Variations in the myocilin gene in patients with open-angle glaucoma.
###end article-title 85
###begin article-title 86
###xml 46 54 <span type="species:ncbi:9606">patients</span>
Myocilin mt1 promoter polymorphism in Turkish patients with primary open angle glaucoma.
###end article-title 86

